Axsome Therapeutics, Inc. (1AXSM)
MTA
184.75
0.00 (0.00%)
Closed
Aug 24, 2026
Day's Range
184.75184.75
52 wk Range
104.10218.20
Financial Statements - 1AXSM - Axsome Therapeutics, Inc.
Revenue
638.49M▲ 95.5%
Net Income
-183.17M▲ 24.7%Net Margin -28.7%
EBITDA
-160.17M▲ 22.6%
Free Cash Flow
-93.88M▲ 13.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 638.49M | 326.52M |
| Cost of Goods | 47.47M | 28.19M |
| Gross Profit | 591.01M | 298.33M |
 Operating Expense | - | - |
| Operating Income | -169.23M | -213.71M |
| Non-Operating Interest | - | - |
| Other Income Expense | -7.91M | -23.80M |
| Pre Tax Income | -183.70M | -243.08M |
| Income Tax | -530K | 71.96K |
| Net Income | -183.17M | -243.15M |
| EPS Basic | -3.68 | -5.99 |
| EPS Diluted | -3.68 | -5.99 |
| Basic Shares Outstanding | 49.74M | 40.56M |
| Diluted Shares Outstanding | 49.74M | 40.56M |
| Ebit | -177.14M | -237.52M |
| Ebitda | -160.17M | -206.97M |
| Net Income Continuous Operations | -183.17M | -243.15M |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
